We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Emerson Electric
EMR
$85B
| $9.65M | 0.02% |
99,950
+872
| +0.9% | +$83K |
|
402
Ulta Beauty
ULTA
$21.6B
| $9.63M | 0.02% |
24,105
+943
| +4% | +$412K |
|
403
Neurocrine Biosciences
NBIX
$18.4B
| $9.59M | 0.02% |
85,221
-10,632
| -11% | -$1.12M |
|
404
Hubbell
HUBB
$25.6B
| $9.56M | 0.02% |
30,488
+5,656
| +23% | +$1.8M |
|
405
Entergy
ETR
$52.4B
| $9.49M | 0.02% |
205,262
-15,092
| -7% | -$736K |
|
406
Packaging Corp of America
PKG
$22.6B
| $9.49M | 0.02% |
61,816
+1,125
| +2% | +$164K |
|
407
Fair Isaac
FICO
$31B
| $9.41M | 0.02% |
10,839
-24
| -0.2% | -$20.6K |
|
408
Automatic Data Processing
ADP
$106B
| $9.39M | 0.02% |
39,042
-3,270
| -8% | -$797K |
|
409
PPG Industries
PPG
$26.5B
| $9.32M | 0.02% |
71,803
-35,966
| -33% | -$5.05M |
|
410
Gartner
IT
$10.4B
| $9.31M | 0.02% |
27,099
-3,200
| -11% | -$1.12M |
|
411
Norfolk Southern
NSC
$76.1B
| $9.28M | 0.02% |
47,120
-34,479
| -42% | -$7.45M |
|
|
JNPR
412
DELISTED
Juniper Networks
JNPR
| $9.27M | 0.02% |
333,516
+170,859
| +105% | +$4.92M |
|
413
Seagate
STX
$169B
| $9.17M | 0.02% |
139,055
-49,885
| -26% | -$3.21M |
|
414
Flowers Foods
FLO
$1.6B
| $9.13M | 0.02% |
411,528
-95,695
| -19% | -$2.29M |
|
415
Align Technology
ALGN
$12.6B
| $9.12M | 0.02% |
29,869
-3,554
| -11% | -$1.23M |
|
416
Autodesk
ADSK
$50.1B
| $9.11M | 0.02% |
44,037
+9,604
| +28% | +$2.02M |
|
417
Ingredion
INGR
$6.48B
| $9.07M | 0.02% |
92,204
+20,254
| +28% | +$2.1M |
|
|
SILK
418
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $9.05M | 0.02% |
603,762
-311,313
| -34% | -$6.48M |
|
419
L3Harris
LHX
$56.9B
| $9.04M | 0.02% |
51,903
-8,418
| -14% | -$1.55M |
|
420
Cleveland-Cliffs
CLF
$6.84B
| $9.02M | 0.02% |
577,012
+28,812
| +5% | +$450K |
|
421
lululemon athletica
LULU
$13.7B
| $9.01M | 0.02% |
23,354
+4,109
| +21% | +$1.57M |
|
422
CMS Energy
CMS
$23B
| $8.98M | 0.02% |
169,149
-65,989
| -28% | -$3.82M |
|
|
SPLK
423
DELISTED
Splunk Inc
SPLK
| $8.9M | 0.02% |
60,886
-20,254
| -25% | -$2.29M |
|
424
Domino's
DPZ
$11.6B
| $8.87M | 0.02% |
23,407
-6,031
| -20% | -$2.32M |
|
425
Iron Mountain
IRM
$37.4B
| $8.83M | 0.02% |
148,493
-14,198
| -9% | -$868K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.